Kan Yonemori

机构：Jikei University School of Medicine, National Cancer Centre Japan, National Cancer Center, National Cancer Center Hospital East, Tokyo National Hospital · ORCID：0000-0002-7624-7611

发表论文 1074 篇 · 总被引 11802 次 · h-index 52

代表论文

• Table S4 from Phase I Study of Rogocekib in Patients with Advanced, Relapsed, or Refractory Malignant Solid Tumors (2026)
• Figure 1 from Phase I Study of Rogocekib in Patients with Advanced, Relapsed, or Refractory Malignant Solid Tumors (2026)
• Table S3 from Phase I Study of Rogocekib in Patients with Advanced, Relapsed, or Refractory Malignant Solid Tumors (2026)
• Table S5 from Phase I Study of Rogocekib in Patients with Advanced, Relapsed, or Refractory Malignant Solid Tumors (2026)
• Table S1 from Phase I Study of Rogocekib in Patients with Advanced, Relapsed, or Refractory Malignant Solid Tumors (2026)
• Figure S1 from Phase I Study of Rogocekib in Patients with Advanced, Relapsed, or Refractory Malignant Solid Tumors (2026)